{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:53Z","timestamp":1760956133378},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,16]]},"DOI":"10.7759\/cureus.23220","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:02:56Z","timestamp":1647450176000},"source":"Crossref","is-referenced-by-count":3,"title":["Familial Essential Thrombocythemia With Novel MPL L502G and G208K Mutations"],"prefix":"10.7759","author":[{"given":"Matthew","family":"Rendo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Cavacece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-ting J","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley W","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Fenderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620713489144","article-title":"Inherited predisposition to myeloproliferative neoplasms","volume":"4","author":"Jones AV","year":"2013","unstructured":"Jones AV, Cross NC. Inherited predisposition to myeloproliferative neoplasms. Ther Adv Hematol. 2013, 4:237-53. 10.1177\/2040620713489144","journal-title":"Ther Adv Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100600746573","article-title":"Incidence and etiology of thrombocytosis in an adult Turkish population","volume":"17","author":"Aydogan T","year":"2006","unstructured":"Aydogan T, Kanbay M, Alici O, Kosar A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets. 2006, 17:328-31. 10.1080\/09537100600746573","journal-title":"Platelets"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3471","article-title":"Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin","volume":"103","author":"Ding J","year":"2004","unstructured":"Ding J, Komatsu H, Wakita A, et al.. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood. 2004, 103:4198-200. 10.1182\/blood-2003-10-3471","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143602","article-title":"Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden","volume":"112","author":"Landgren O","year":"2008","unstructured":"Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Bj\u00f6rkholm M. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood. 2008, 112:2199-204. 10.1182\/blood-2008-03-143602","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08500.x","article-title":"Advances in understanding the pathogenesis of familial thrombocythaemia","volume":"152","author":"Teofili L","year":"2011","unstructured":"Teofili L, Larocca LM. Advances in understanding the pathogenesis of familial thrombocythaemia. Br J Haematol. 2011, 152:701-12. 10.1111\/j.1365-2141.2010.08500.x","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-4852","article-title":"Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders","volume":"108","author":"Bellann\u00e9-Chantelot C","year":"2006","unstructured":"Bellann\u00e9-Chantelot C, Chaumarel I, Labopin M, et al.. Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood. 2006, 108:346-52. 10.1182\/blood-2005-12-4852","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007542","article-title":"Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis","volume":"95","author":"Teofili L","year":"2010","unstructured":"Teofili L, Giona F, Torti L, et al.. Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. Haematologica. 2010, 95:65-70. 10.3324\/haematol.2009.007542","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.177","article-title":"Evidence and expertise in the management of polycythemia vera and essential thrombocythemia","volume":"22","author":"Finazzi G","year":"2008","unstructured":"Finazzi G, Barbui T. Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia. 2008, 22:1494-502. 10.1038\/leu.2008.177","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11801","article-title":"A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family","volume":"93","author":"Liu K","year":"2008","unstructured":"Liu K, Kralovics R, Rudzki Z, et al.. A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica. 2008, 93:706-14. 10.3324\/haematol.11801","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine RL","year":"2007","unstructured":"Levine RL, Pardanani A, Tefferi A, Gilliland DG. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer. 2007, 7:673-83. 10.1038\/nrc2210","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2019.7868","article-title":"MPL Y252H and MPL F126fs mutations in essential thrombocythemia: case series and review of literature","volume":"11","author":"Elsayed AG","year":"2019","unstructured":"Elsayed AG, Ranavaya A, Jamil MO. MPL Y252H and MPL F126fs mutations in essential thrombocythemia: case series and review of literature. Hematol Rep. 2019, 11:7868. 10.4081\/hr.2019.7868","journal-title":"Hematol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90650-familial-essential-thrombocythemia-with-novel-mpl-l502g-and-g208k-mutations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:43Z","timestamp":1707507343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90650-familial-essential-thrombocythemia-with-novel-mpl-l502g-and-g208k-mutations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.23220","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}